Latest webfg news

Indivior shrinks board following pressure from activist investor	04 Mar
London close: Stocks mixed on corporate earnings, Trump tariff threats	27 Feb
Pharma veteran Ciaffoni to take CEO reins at Indivior	27 Feb
Indivior's opioid addiction treatment gets FDA label change approval	24 Feb
London close: Stocks slip as US jobless claims rise	20 Feb
Indivior ends year better than expected, flags tough 2025	20 Feb
London close: Stocks mixed as US inflation comes in hot	12 Feb
Indivior flags delay to FDA review of Sublocade label change	12 Feb
Indivior makes board changes after move to Nasdaq	17 Dec
Oaktree Capital calls on Indivior to refresh board of directors	07 Nov
London close: Stocks mixed after barrage of corporate updates	24 Oct
Indivior confident after strong third quarter	24 Oct
London close: Stocks red as US inflation, jobless claims top forecasts	10 Oct
Indivior shares tank after another profit warning	10 Oct
London close: Stocks slip as US non-farm payrolls undershoot	06 Sep
Indivior CUD study fails to meet primary and secondary endpoints	04 Sep
London close: Stocks mixed on tsunami of updates, US GDP data	25 Jul
Indivior shares rebound on $100m buyback plan	25 Jul
London close: Stocks mixed as UK inflation holds steady	17 Jul
London close: Stocks slip as investors digest Powell's comments	09 Jul